Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | KCNH3 | Q9ULD8 | 2/20 | 0.51 |
| ▸ | F2R | P25116 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 6/20 | 0.45 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8667014 | 0.93 | F2R (0.56) | ABL1MAPTHTTCYP1A2CYP2D6 | |
| SCHEMBL22176875 | 0.92 | ABL1 (0.53) | ABL1MAPTHTTCYP1A2CYP2D6 | |
| SCHEMBL13383271 | 0.91 | ABL1 (0.47) | ABL1MAPTHTTCYP1A2CYP2D6 | |
| SCHEMBL10439139 | 0.89 | ABL1 (0.54) | ABL1MAPTHTTCYP1A2CYP2D6 | |
| SCHEMBL20197373 | 0.88 | MAPT (0.71) | ABL1MAPTHTTCYP1A2CYP2D6 | |
| SCHEMBL2920696 | 0.88 | EPHX1 (0.59) | ABL1MAPTALDH1A1EPHX1 | |
| SCHEMBL6231348 | 0.88 | ABL1 (0.49) | ABL1MAPTHTTCYP1A2CYP2D6 | |
| SCHEMBL5609022 | 0.87 | MAPT (0.69) | ABL1MAPTHTTCYP1A2CYP2D6 | |
| SCHEMBL19968723 | 0.87 | ABL1 (0.51) | ABL1MAPTHTTCYP1A2CYP2D6 | |
| SCHEMBL4611763 | 0.87 | ABL1 (0.47) | ABL1MAPTHTTCYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2142496-B1 | LUBRICATING COMPOSITIONS CONTAINING ASHLESS CATALYTIC ANTIOXIDANT ADDITIVES | EXXONMOBIL RES & ENG CO (US) | 2013-04-17 | — | — | EP | disclosed |
| US-8080601-B2 | Lubricating compositions containing ashless catalytic antioxidant additives | EXXOMMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2011-12-20 | — | — | US | disclosed |
| EP-2142496-A1 | LUBRICATING COMPOSITIONS CONTAINING ASHLESS CATALYTIC ANTIOXIDANT ADDITIVES | ExxonMobil Research and Engineering Company (US) | 2010-01-13 | — | — | EP | disclosed |
| US-20080248984-A1 | Lubricating compositions containing ashless catalytic antioxidant additives | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2008-10-09 | — | — | US | disclosed |
| WO-2008121304-A1 | LUBRICATING COMPOSITIONS CONTAINING ASHLESS CATALYTIC ANTIOXIDANT ADDITIVES | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2008-10-09 | — | — | WO | disclosed |
| US-5710335-A | REACTING RESORCIN WITH PRIMARY AMINE THEN ALKYL HALIDE | MITSUI TOATSU CHEMICALS, INC. (JP) | 1998-01-20 | — | — | US | disclosed |
| EP-0111844-B1 | PROCESS FOR THE PREPARATION OF 3-ACYLAMINOANILINES | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-11-27 | — | — | EP | disclosed |
| US-4552699-A | Process for the preparation of 3-acylaminoanilines | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-11-12 | — | — | US | disclosed |
| EP-0111844-A1 | Process for the preparation of 3-acylaminoanilines | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080248984-A1 | Lubricating compositions containing ashless catalytic antioxidant additives | GPX1, SOD1, CAT | ABL1 1077/4885MAPT 1203/4885HTT 1308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.